Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naive patients with advanced NSCLC

Publication date: Available online 19 June 2021Source: Pharmacological ResearchAuthor(s): Hou-Qun Ying, Yu-Cui Liao, Yan-Ran Luo, Gang Xiong, Ying Huang, Ruo-Wei Nie, Cui-Fen Xiong, Xue-Xin Cheng
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research